Tag: Teduglutide

In clinical trials, nearly 70% of adult patients who received GATTEX experienced a significant reduction in their weekly parenteral support (PS) volume. The **GATTEX kit** is used to administer teduglutide, a crucial medication designed for adults and children with Short Bowel Syndrome (SBS) who require supplemental intravenous feeding.

Medications known as glucagon-like peptide-2 (GLP-2) analogues have enabled some patients with Short Bowel Syndrome (SBS) to significantly reduce their dependence on intravenous nutrition, with one study showing a 92% rate of reaching enteral autonomy in a monitored setting. This class of drugs mimics a natural gut hormone to promote intestinal healing and improve absorption.

In clinical trials, teduglutide was shown to significantly reduce dependence on parenteral support (IV nutrition and hydration) in patients with Short Bowel Syndrome (SBS). So, **what is a teduglutide injection used for**? It is prescribed to enhance intestinal absorption in individuals with SBS who require intravenous support.